Preferred Label : Onasemnogene Abeparvovec;

UNII : MLU3LU3EVV;

CAS number : 1922968-73-7;

NCI Metathesaurus CUI : CL1412263;

Details


Main resources

You can consult :


https://ansm.sante.fr/informations-de-securite/zolgensma-onasemnogene-abeparvovec-cas-dinsuffisance-hepatique-aigue-dissue-fatale
2023
false
false
false
France
French
pharmacovigilance note
risk
onasemnogene abeparvovec-xioi
Onasemnogene Abeparvovec
onasemnogene abeparvovec
liver function tests
continuity of patient care
Monitoring of liver function (regime/therapy)
liver failure, acute
child
infant
liver failure, acute
guidelines for drug use

---
https://ansm.sante.fr/informations-de-securite/zolgensma-r-onasemnogene-abeparvovec-risque-de-microangiopathie-thrombotique
2021
false
false
false
France
French
pharmacovigilance note
Onasemnogene Abeparvovec
onasemnogene abeparvovec
thrombotic microangiopathies
gene therapy
spinal muscular atrophies of childhood
infusions, intravenous
guidelines for drug use
drug monitoring
continuity of patient care
infant
onasemnogene abeparvovec-xioi
genetic therapy
Zolgensma
biological products
recombinant fusion proteins

---
https://ansm.sante.fr/tableau-atu-rtu/zolgensma-2-x-1013-genomes-de-vecteur-ml-solution-pour-perfusion
2021
false
true
false
France
French
Onasemnogene Abeparvovec
Onasemnogene Abeparvovec
summary of product characteristics
package leaflet
guidelines for drug use
onasemnogene abeparvovec
spinal muscular atrophies of childhood
HMN (Hereditary motor neuropathy) proximal type I
infusions, intravenous
onasemnogene abeparvovec-xioi
Zolgensma
biological products
recombinant fusion proteins

---
Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.